• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨脂质偶联 AS1411 适体的构象行为和聚集特性。

Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.

机构信息

Department of Chemical Sciences, University of Naples Federico II, Via Cintia 21, I-80126 Napoli, Italy.

Department of Chemical Sciences, University of Naples Federico II, Via Cintia 21, I-80126 Napoli, Italy; Institute of Biostructures and Bioimages, CNR, Via Mezzocannone 16, I-80134 Napoli, Italy.

出版信息

Int J Biol Macromol. 2018 Oct 15;118(Pt B):1384-1399. doi: 10.1016/j.ijbiomac.2018.06.137. Epub 2018 Jul 4.

DOI:10.1016/j.ijbiomac.2018.06.137
PMID:30170359
Abstract

AS1411 is a nucleolin-binding aptamer which attracted great interest as active targeting ligand for the selective delivery of therapeutic agents to tumour cells. In this work we selected three AS1411 derivatives 5'-conjugated with lipophilic tails and studied their properties in view of their application in liposomial formulations and/or lipid coated-nanoparticles for targeted therapies. The conformational behaviour of these AS1411 analogs has been investigated in comparison with the unmodified aptamer by CD, UV, PAGE, SEC-HPLC, DLS and thioflavin T (ThT) fluorescence assays to get insight in their secondary structure and aggregation properties. This study has been performed in pseudo-physiological buffers mimicking the extra- and intracellular environments, and at different concentrations in the μM range, paying special attention to the effects of the lipophilic tail on the overall aptamer conformation. The 5'-lipidated AS1411 derivatives proved to fold into stable, parallel unimolecular G-quadruplex structures, forming large aggregates, mainly micelles, at conc. >10 μM. Preliminary bioscreenings on selected cancer cells showed that these derivatives are less cytotoxic than AS1411, but maintain a similar biological behaviour. This study demonstrated that lipophilic tails dramatically favour the formation of AS1411 aggregates, however not impairing the formation and thermal stability of its peculiar G4 motifs.

摘要

AS1411 是一种核仁素结合适体,作为靶向配体用于将治疗剂选择性递送至肿瘤细胞,引起了极大的关注。在这项工作中,我们选择了三个带有亲脂尾巴的 5'-AS1411 衍生物,并研究了它们在脂质体制剂和/或脂质包裹纳米颗粒中的应用特性,以用于靶向治疗。通过 CD、UV、PAGE、SEC-HPLC、DLS 和硫黄素 T(ThT)荧光分析等方法,比较了这些 AS1411 类似物与未修饰适体的构象行为,以深入了解它们的二级结构和聚集特性。这项研究是在模拟细胞内外环境的类生理缓冲液中进行的,并在 μM 范围内的不同浓度下进行,特别关注亲脂尾巴对整体适体构象的影响。5'-脂质化的 AS1411 衍生物被证明能够折叠成稳定的、平行的单分子 G-四链体结构,在浓度>10μM 时形成大的聚集物,主要是胶束。对选定癌细胞的初步生物筛选表明,这些衍生物的细胞毒性比 AS1411 低,但保持相似的生物学行为。这项研究表明,亲脂尾巴极大地促进了 AS1411 聚集物的形成,但不影响其特殊 G4 基序的形成和热稳定性。

相似文献

1
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers.探讨脂质偶联 AS1411 适体的构象行为和聚集特性。
Int J Biol Macromol. 2018 Oct 15;118(Pt B):1384-1399. doi: 10.1016/j.ijbiomac.2018.06.137. Epub 2018 Jul 4.
2
AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.AS1411 衍生物作为 G-四链体配体载体用于宫颈癌细胞。
Int J Pharm. 2019 Sep 10;568:118511. doi: 10.1016/j.ijpharm.2019.118511. Epub 2019 Jul 10.
3
Toward G-Quadruplex-Based Anticancer Agents: Biophysical and Biological Studies of Novel AS1411 Derivatives.基于 G-四链体的抗癌剂:新型 AS1411 衍生物的生物物理和生物学研究。
Int J Mol Sci. 2020 Oct 21;21(20):7781. doi: 10.3390/ijms21207781.
4
Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.基于适体的靶向递送至宫颈癌细胞中的 G-四链体配体。
Sci Rep. 2019 May 28;9(1):7945. doi: 10.1038/s41598-019-44388-9.
5
Cell Surface Nucleolin as a Promising Receptor for Effective AS1411 Aptamer-Mediated Targeted Drug Delivery into Cancer Cells.细胞表面核仁素作为一种有前景的受体,可实现AS1411适配体介导的有效靶向药物递送至癌细胞。
Curr Drug Deliv. 2018;15(9):1323-1329. doi: 10.2174/1567201815666180724104451.
6
Bioactivity of 2'-deoxyinosine-incorporated aptamer AS1411.掺入2'-脱氧肌苷的适配体AS1411的生物活性。
Sci Rep. 2016 May 19;6:25799. doi: 10.1038/srep25799.
7
G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: Uses and mechanisms.G-四链体寡核苷酸 AS1411 作为一种癌症靶向剂:用途和机制。
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt B):1414-1428. doi: 10.1016/j.bbagen.2016.12.015. Epub 2016 Dec 20.
8
Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.用(99m)Tc标记的AS1411适配体对前列腺肿瘤细胞进行肿瘤靶向。
J Drug Target. 2015;23(6):497-505. doi: 10.3109/1061186X.2015.1009075. Epub 2015 Feb 12.
9
Phthalocyanines for G-quadruplex aptamers binding.用于 G-四链体适体结合的酞菁
Bioorg Chem. 2020 Jul;100:103920. doi: 10.1016/j.bioorg.2020.103920. Epub 2020 May 7.
10
Binding affinity and conformation of a conjugated AS1411 aptamer at a cationic lipid bilayer interface.与阳离子脂质双层界面的共轭 AS1411 适体的结合亲和力和构象。
Phys Chem Chem Phys. 2022 Apr 13;24(15):9018-9028. doi: 10.1039/d1cp05753g.

引用本文的文献

1
An aptamer-conjugated mesoporous polydopamine formulation for synergistic targeted and photothermal therapy of hepatocellular carcinoma.一种用于肝细胞癌协同靶向和光热治疗的适配体共轭介孔聚多巴胺制剂。
Int J Pharm X. 2025 Apr 24;9:100335. doi: 10.1016/j.ijpx.2025.100335. eCollection 2025 Jun.
2
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment.评估用于杜氏肌营养不良症治疗的熊去氧胆酸共轭寡核苷酸肠道渗透性的体外研究
Pharmaceutics. 2024 Aug 1;16(8):1023. doi: 10.3390/pharmaceutics16081023.
3
Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview.
免疫检查点抑制剂和适体的癌症免疫治疗:概述。
Med Oncol. 2023 Dec 29;41(1):40. doi: 10.1007/s12032-023-02267-4.
4
Anti-nucleolin aptamer AS1411: an advancing therapeutic.抗核仁素适配体AS1411:一种不断发展的治疗药物。
Front Mol Biosci. 2023 Sep 21;10:1217769. doi: 10.3389/fmolb.2023.1217769. eCollection 2023.
5
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better!靶向突变型亨廷顿蛋白的 G-四链体形成适体的截短类似物:更短更好!
Int J Mol Sci. 2022 Oct 17;23(20):12412. doi: 10.3390/ijms232012412.
6
Basal Cell Carcinoma: Pathology, Current Clinical Treatment, and Potential Use of Lipid Nanoparticles.基底细胞癌:病理学、当前临床治疗及脂质纳米颗粒的潜在应用
Cancers (Basel). 2022 Jun 3;14(11):2778. doi: 10.3390/cancers14112778.
7
Antisense Oligonucleotides Conjugated with Lipophilic Compounds: Synthesis and In Vitro Evaluation of Exon Skipping in Duchenne Muscular Dystrophy.与脂溶性化合物偶联的反义寡核苷酸:杜氏肌营养不良症外显子跳跃的合成与体外评价。
Int J Mol Sci. 2022 Apr 12;23(8):4270. doi: 10.3390/ijms23084270.
8
Progress in cancer drug delivery based on AS1411 oriented nanomaterials.基于 AS1411 导向纳米材料的癌症药物输送进展。
J Nanobiotechnology. 2022 Jan 31;20(1):57. doi: 10.1186/s12951-022-01240-z.
9
Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases.纳米颗粒引导的脑药物递送:扩展神经退行性疾病的治疗方法
Pharmaceutics. 2021 Nov 8;13(11):1897. doi: 10.3390/pharmaceutics13111897.
10
Charge-Transfer Interactions Stabilize G-Quadruplex-Forming Thrombin Binding Aptamers and Can Improve Their Anticoagulant Activity.电荷转移相互作用稳定形成 G-四链体的凝血酶结合适体,并能提高其抗凝活性。
Int J Mol Sci. 2021 Sep 2;22(17):9510. doi: 10.3390/ijms22179510.